Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis.

BACKGROUND: Multiple treatments for painful diabetic peripheral neuropathy are available. PURPOSE: To evaluate the comparative effectiveness of oral and topical analgesics for diabetic neuropathy. DATA SOURCES: Multiple electronic databases between January 2007 and April 2014, without language restriction. STUDY SELECTION: Parallel or crossover randomized, controlled trials that evaluated pharmacologic treatments for adults with painful diabetic peripheral neuropathy. DATA EXTRACTION: Duplicate extraction of study data and assessment of risk of bias. DATA SYNTHESIS: 65 randomized, controlled trials involving 12 632 patients evaluated 27 pharmacologic interventions. Approximately one half of these studies had high or unclear risk of bias. Nine head-to-head trials showed greater pain reduction associated with serotonin-norepinephrine reuptake inhibitors (SNRIs) than anticonvulsants (standardized mean difference [SMD], -0.34 [95% credible interval {CrI}, -0.63 to -0.05]) and with tricyclic antidepressants (TCAs) than topical capsaicin 0.075%. Network meta-analysis showed that SNRIs (SMD, -1.36 [CrI, -1.77 to -0.95]), topical capsaicin (SMD, -0.91 [CrI, -1.18 to -0.08]), TCAs (SMD, -0.78 [CrI, -1.24 to -0.33]), and anticonvulsants (SMD, -0.67 [CrI, -0.97 to -0.37]) were better than placebo for short-term pain control. Specifically, carbamazepine (SMD, -1.57 [CrI, -2.83 to -0.31]), venlafaxine (SMD, -1.53 [CrI, -2.41 to -0.65]), duloxetine (SMD, -1.33 [CrI, -1.82 to -0.86]), and amitriptyline (SMD, -0.72 [CrI, -1.35 to -0.08]) were more effective than placebo. Adverse effects included somnolence and dizziness with TCAs, SNRIs, and anticonvulsants; xerostomia with TCAs; and peripheral edema and burning sensation with pregabalin and capsaicin. LIMITATION: Confidence in findings was limited because most evidence came from indirect comparisons of trials with short (≤3 months) follow-up and unclear or high risk of bias. CONCLUSION: Several medications may be effective for short-term management of painful diabetic neuropathy, although their comparative effectiveness is unclear. PRIMARY FUNDING SOURCE: Mayo Foundation for Medical Education and Research.

Systematic reviews to ascertain the safety of diabetes medications.

Clinicians and patients with type 2 diabetes enjoy an expanding list of medications to improve glycemic control. With this expansion has come a flurry of concerns about the safety of these antihyperglycemic agents, concerns that affect judgments about the risk/benefit balance of therapy. Some of these safety signals have been identified through the synthesis of existing research evidence. Thus, it has become important for clinicians and clinical policymakers to understand the strengths and limitations of systematic reviews and meta-analyses in determining the safety of diabetes medications. In this paper, we highlight key safety concerns with diabetes medications and discuss the role evidence synthesis plays in each, with special attention to its strengths and limitations.

Inpatient glycemic management in noncritically ill patients: Updated guidelines.

Hyperglycemia is common in hospitalized patients and is traditionally managed with scheduled and correctional doses of insulin. The authors present an overview of the latest (2022) guidelines from the Endocrine Society on inpatient hyperglycemia management in noncritically ill patients, which includes a role for newer diabetes technologies and nontraditional insulin and noninsulin therapies.

Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations.

Bariatric and metabolic surgery is an effective treatment for patients with severe obesity and obesity-related diseases. In patients with type 2 diabetes, it provides marked improvement in glycemic control and even remission of diabetes. In patients with type 1 diabetes, bariatric surgery may offer improvement in insulin sensitivity and other cardiometabolic risk factors, as well as amelioration of the mechanical complications of obesity. Because of these positive outcomes, there are increasing numbers of patients with diabetes who undergo bariatric surgical procedures each year. Prior to surgery, efforts should be made to optimize glycemic control. However, there is no need to delay or withhold bariatric surgery until a specific glycosylated hemoglobin target is reached. Instead, treatment should focus on avoidance of early postoperative hyperglycemia. In general, oral glucose-lowering medications and noninsulin injectables are not favored to control hyperglycemia in the inpatient setting. Hyperglycemia in the hospital is managed with insulin, aiming for perioperative blood glucose concentrations between 80 and 180 mg/dL. Following surgery, substantial changes of the antidiabetic medication regimens are common. Patients should have a clear understanding of the modifications made to their treatment and should be followed closely thereafter. In this review article, we describe practical recommendations for the perioperative management of diabetes in patients with type 2 or type 1 diabetes undergoing bariatric surgery. Specific recommendations are delineated based on the different treatments that are currently available for glycemic control, including oral glucose-lowering medications, noninsulin injectables, and a variety of insulin regimens.

Rapid onset type-1 diabetes and diabetic ketoacidosis secondary to nivolumab immunotherapy: a review of existing literature.

Nivolumab is a programmed cell death receptor (PD-1) inhibitor that is increasingly used for various malignancies, both as a first line agent and as salvage therapy. Being a PD-1/PD-1 ligand checkpoint inhibitor, it is known to cause autoimmune inflammation of various organs and has been associated with thyroiditis, insulitis, colitis, hepatitis and encephalitis to name a few. There are increasing reports of nivolumab leading to acute onset fulminant type 1 diabetes and diabetic ketoacidosis (DKA). We present a case of a 68-year-old man who developed DKA after 2 doses of nivolumab for metastatic melanoma. He was found to have type 1 diabetes, but no diabetes related antibodies were positive. He recovered from diabetes and continues to use insulin 1 year after his diagnosis. This case and associated review illustrates the importance of educating and monitoring patients who start nivolumab therapy regarding this potentially life threatening complication.

Hemodynamic Patterns Identified by Impedance Cardiography Predict Mortality in the General Population: The PREVENCION Study.

Background Blood pressure is determined by the interactions between the heart and arterial properties, and subjects with identical blood pressure may have substantially different hemodynamic determinants. Whether arterial hemodynamic indices quantified by impedance cardiography ( ICG ), a simple operator-independent office procedure, independently predict all-cause mortality in adults from the general population, and specifically among those who do not meet criteria for American College of Cardiology/American Heart Association stage 2 hypertension, is currently unknown. Methods and Results We studied 1639 adults aged 18 to 80 years from the general population. We used ICG to measure hemodynamic parameters and metrics of cardiac function. We assessed the relationship between hemodynamic parameters measured at baseline and all-cause mortality over a mean follow-up of 10.9 years. Several ICG parameters predicted death. The strongest predictors were total arterial compliance index (standardized hazard ratio=0.38; 95% confidence interval=0.31-0.46; P<0.0001) and indices of cardiac contractility: velocity index (standardized hazard ratio=0.45; 95% confidence interval=0.37-0.55; P<0.0001) and acceleration index (standardized hazard ratio=0.44; 95% confidence interval=0.35-0.55; P<0.0001). These remained independently predictive of death after adjustment for multiple confounders, as well as systolic and diastolic blood pressure. Among subjects without stage 2 hypertension (n=1563), indices of cardiac contractility were independently predictive of death and identified a subpopulation (25% of non-stage-2 hypertensives) that demonstrated a high 10-year mortality risk, equivalent to that of stage 2 hypertensives. Conclusions Hemodynamic patterns identified by ICG independently predict mortality in the general population. The predictive value of ICG applies even in the absence of American College of Cardiology/American Heart Association stage 2 hypertension and identifies higher-risk individuals who are in earlier stages of the hypertension continuum.

Prevalence of the metabolic syndrome in Peruvian Andean hispanics: the PREVENCION study.

Data regarding the prevalence of metabolic syndrome (MTS) in Andean populations are limited. We evaluated the prevalence of MTS according to American Heart Association/National Heart, Lung and Blood Institute criteria among 1878 subjects in the PREVENCION study in Peru. In women, the most common component was low HDL cholesterol (60.9%) followed by abdominal obesity (36.9%). In men, the most common component was elevated triglycerides (52.0%) followed by low HDL cholesterol (32.5%), whereas the prevalence of abdominal obesity was 14%. Abnormal fasting glucose was the least common component in men (5.4%) and women (5.0%). The prevalence of MTS was significantly higher in women compared to men (23.2% versus 14.3%) and increased steeply with age, particularly in women (p<0.0001). Using body mass index (BMI>or=30kg/m2) instead of waist circumference as a component of the MTS lead to equivalent prevalence estimates of MTS in men but significantly underestimated the prevalence in women. The MTS is highly prevalent among Peruvian Andeans, particularly in older women. The pattern of MTS components in this Andean population is characterized by a high prevalence of dyslipidemia and a relatively low prevalence of elevated fasting glucose. Further studies are required to characterize genetic and environmental determinants of these patterns.

BE SMART: strategies for foot care and prevention of foot complications in patients with diabetes.

BACKGROUND: Diabetic foot ulcers and lower extremity amputations are common complications of diabetes mellitus that are associated with substantial morbidity, loss of quality of life, disability, and a high social and economic burden. The implementation of strategies to prevent these complications is a key aspect of diabetes care. OBJECTIVES: The objective of this article is to provide an overview of the available evidence on preventive diabetic foot care. STUDY DESIGN: Literature review. METHODS: Narrative review based on a thorough search of previous relevant studies, systematic reviews, and clinical guidelines on diabetic foot care published in English. RESULTS: We describe diabetic foot care strategies that can be categorized within defined domains for the purpose of helping clinicians to remember them. We use the mnemonic "BE SMART" (Be aware of the risk factors, Educate patients and health providers, Structured clinical assessment, Metabolic evaluation and management, Assessment of Risk, and Team care) to organize these domains. CONCLUSION: Diabetic foot ulcers and lower extremity amputations are potentially preventable complications. Clinicians taking care of patients with diabetes should know, understand, and remember the multiple aspects of diabetic foot care. CLINICAL RELEVANCE: This review can be used as a reference source for those interested in the care of diabetic foot. It highlights the importance of risk factor recognition, education, a structured clinical and metabolic evaluation, and also the importance of assigning patients a risk category that can help guiding multidisciplinary management efforts.

[Shared decision making and minimal disruptive medicine in the management of chronic diseases]. / Toma de decisiones compartidas y medicina mínimamente impertinente en el manejo de las enfermedades crónicas.

Chronic diseases are the leading cause of morbidity and mortality worldwide. These conditions require considerable time investment and resources from the health system in Peru, as well as from patients and their families. Paradoxically, the developed medical strategies for managing these conditions generate a constant and increasing burden for the patient and their environment, which affects quality of life and therapeutic results. In this article, the role of shared decision making and minimal disruptive medicine will be described as strategies to address these problems.

A systematic review of shared decision making interventions in chronic conditions: a review protocol.

BACKGROUND: Chronic conditions are a major source of morbidity, mortality and cost worldwide. Shared decision making is one way to improve care for patients with chronic conditions. Although it has been widely studied, the effect of shared decision making in the context of chronic conditions is unknown. METHODS/DESIGN: We will perform a systematic review with the objective of determining the effectiveness of shared decision making interventions for persons diagnosed with chronic conditions. We will search the following databases for relevant articles: PubMed, Scopus, Ovid MEDLINE, Ovid EMBASE, Ovid EBM Reviews CENTRAL, CINAHL, and Ovid PsycInfo. We will also search clinical trial registries and contact experts in the field to identify additional studies. We will include randomized controlled trials studying shared decision making interventions in patients with chronic conditions who are facing an actual decision. Shared decision making interventions will be defined as any intervention aiming to facilitate or improve patient and/or clinician engagement in a decision making process. We will describe all studies and assess their quality. After adjusting for missing data, we will analyze the effect of shared decision making interventions on outcomes in chronic conditions overall and stratified by condition. We will evaluate outcomes according to an importance ranking informed by a variety of stakeholders. We will perform several exploratory analyses including the effect of author contact on the estimates of effect. DISCUSSION: We anticipate that this systematic review may have some limitations such as heterogeneity and imprecision; however, the results will contribute to improving the quality of care for individuals with chronic conditions and facilitate a process that allows decision making that is most consistent with their own values and preferences. TRIAL REGISTRATION: PROSPERO Registration Number: CRD42013005784.

Metabolic syndrome in andean populations.

The metabolic syndrome, a cluster of metabolic abnormalities, has been linked to both cardiovascular disease and type 2 diabetes mellitus risk. Several studies have shown that ethnicity is an important determinant for risk of developing the metabolic syndrome; therefore, further understanding of the prevalence and presentation of the metabolic syndrome in various ethnic groups is needed. Latin American communities, and particularly Andean countries, are largely understudied in relation to the metabolic syndrome and until recently, the prevalence of this metabolic disturbance in Andean Hispanics was unknown. Nonetheless, recent (and ongoing) population studies are providing important data regarding the prevalence and patterns of the metabolic syndrome in various Andean countries. This review aims to summarize and interpret the information provided by these studies in an effort to better characterize the metabolic syndrome in Andean Hispanics.

Prevalence of lifestyle-related cardiovascular risk factors in Peru: the PREVENCION study.

OBJECTIVES: To estimate the prevalence of lifestyle-related cardiovascular risk factors in the adult population of Arequipa, the second largest city in Peru. METHODS: The prevalence and patterns of smoking, alcohol drinking, lack of physical activity, high-fat diet, and low fruit and vegetable intake were evaluated among 1 878 subjects (867 men and 1 011 women) in a population-based study. RESULTS: The age-standardized prevalence of current smoking, former smoking, and never smoking were 21.6%, 14.3%, and 64.1%, respectively. The prevalence of current smoking was significantly higher in men than women (31.1% vs. 12.1%; P < 0.01). The prevalence of current alcohol use was 37.7% and significantly higher in men than women (55.5% vs. 19.7%; P < 0.01). Similarly, the prevalence of binge drinking was 21.2%, and the percentage of men who binge drink (36.1%) was significantly higher than for women (6.4%; P < 0.01). The vast majority of alcohol drinkers reported a pattern of alcohol consumption mainly on weekends and holidays rather than regular drinking with meals during the week. The proportion of insufficiently active people was 57.6% and was significantly higher in women than men (63.3% vs. 51.9%; P < 0.01). Overall, 42.0% of adults reported consuming high-fat diets, 34.5% reported low fruit intake, and 33.3% reported low vegetable intake. CONCLUSIONS: The high prevalence of lifestyle-related cardiovascular risk factors found in this Andean population is of concern. Preventive programs are urgently needed to deal with this growing problem.

Prevalence and patterns of hypertension in Peruvian Andean Hispanics: the PREVENCION study.

Cardiovascular disease is emerging as a leading cause of morbidity and mortality in Latin America. Population-based data regarding the prevalence of hypertension and hypertension subtypes in Andean Hispanic populations are scarce. The authors performed a population-based study that included 1878 Peruvian Andean adults to determine: (1) the prevalence, awareness, and control of hypertension and (2) the relative frequency of hypertension subtypes (systolic vs. diastolic). The prevalence of hypertension was 15.7% (95% confidence interval [CI], 14.0%-17.4%), did not differ by gender, and increased steeply with age, particularly in women. Awareness, treatment, and control rates were 47.9%, 39.5%, and 14%, respectively. Diastolic blood pressure increased until age 50 years and reached a plateau thereafter, whereas mean arterial pressure continued to increase with age even after age 50 years. Furthermore, in sharp contrast with the United States population, the predominant type of hypertension was systodiastolic (41.7%; 95% CI, 35.1%-48.5%). Isolated systolic hypertension accounted for only 29.3% of cases (95% CI, 23.9%-35.4%) and was responsible for a minority of cases in all age groups before age 70 years. Hypertension subtypes in this Andean population seem to differ significantly from those present in the United States population, with a much larger proportion of systodiastolic and diastolic hypertension even with advanced age. These differences result from interactions between hemodynamic and structural factors, and further studies aimed at characterizing their genetic and environmental determinants and implications in end-organ damage and prognosis in this population may contribute to understanding the pathophysiology of hypertension.

Prevalence of lifestyle-related cardiovascular risk factors in Peru: the PREVENCION study / Prevalencia de factores de riesgo cardiovascular relacionados con el estilo de vida en Perú: el estudio PREVENCIÓN

OBJECTIVES: To estimate the prevalence of lifestyle-related cardiovascular risk factors in the adult population of Arequipa, the second largest city in Peru. METHODS: The prevalence and patterns of smoking, alcohol drinking, lack of physical activity, high-fat diet, and low fruit and vegetable intake were evaluated among 1 878 subjects (867 men and 1 011 women) in a population-based study. RESULTS: The age-standardized prevalence of current smoking, former smoking, and never smoking were 21.6 percent, 14.3 percent, and 64.1 percent, respectively. The prevalence of current smoking was significantly higher in men than women (31.1 percent vs. 12.1 percent; P < 0.01). The prevalence of current alcohol use was 37.7 percent and significantly higher in men than women (55.5 percent vs. 19.7 percent; P < 0.01). Similarly, the prevalence of binge drinking was 21.2 percent, and the percentage of men who binge drink (36.1 percent) was significantly higher than for women (6.4 percent; P < 0.01). The vast majority of alcohol drinkers reported a pattern of alcohol consumption mainly on weekends and holidays rather than regular drinking with meals during the week. The proportion of insufficiently active people was 57.6 percent and was significantly higher in women than men (63.3 percent vs. 51.9 percent; P < 0.01). Overall, 42.0 percent of adults reported consuming high-fat diets, 34.5 percent reported low fruit intake, and 33.3 percent reported low vegetable intake. CONCLUSIONS: The high prevalence of lifestyle-related cardiovascular risk factors found in this Andean population is of concern. Preventive programs are urgently needed to deal with this growing problem.

OBJETIVOS: Estimar la prevalencia de factores de riesgo cardiovascular relacionados con el estilo de vida de adultos de Arequipa, la segunda mayor ciudad de Perú. MÉTODOS: Se realizó un estudio de base poblacional para evaluar la prevalencia y los patrones de consumo de tabaco y bebidas alcohólicas, la falta de actividad física, la dieta rica en grasas y el bajo consumo de frutas y vegetales en 1 878 personas (867 hombres y 1 011 mujeres). RESULTADOS: Las prevalencias estandarizadas por la edad de los fumadores actuales, pasados y de los que nunca fumaron fueron 21,6 por ciento, 14,3 por ciento y 64,1 por ciento, respectivamente. La prevalencia de tabaquismo fue significativamente mayor en los hombres que en las mujeres (31,1 por ciento frente a 12,1 por ciento; P < 0,01). La prevalencia del consumo de bebidas alcohólicas fue de 37,7 por ciento, significativamente mayor en los hombres que en las mujeres (55,5 por ciento frente a 19,7 por ciento; P < 0,01). La prevalencia del consumo excesivo de alcohol fue de 21,1 por ciento, mayor en los hombres que en las mujeres (36,1 por ciento frente a 6,4 por ciento; P < 0,01). La gran mayoría de los bebedores presentó un patrón de consumo concentrado fundamentalmente en los fines de semana y los días feriados, más que el consumo habitual con las comidas en los días laborables. La proporción de personas con insuficiente actividad fue de 57,6 por ciento, significativamente mayor en las mujeres que en los hombres (63,3 por ciento frente a 51,9 por ciento; P < 0,01). En general, 42,0 por ciento de los adultos informaron consumir dietas ricas en grasas, 34,5 por ciento dijo tener un bajo consumo de frutas y 33,3 por ciento un bajo consumo de vegetales. CONCLUSIONES: La alta prevalencia de factores de riesgo cardiovascular relacionados con el estilo de vida encontrada en esta población de los Andes es preocupante. Se deben implementar urgentemente programas preventivos para resolver este creciente problema.

Prevalencia de sobrepeso y obesidad en la población adulta de Arequipa Metropolitana: resultados del estudio prevención / Prevalencia of overweight and obesity in the adult population of Arequipa Metropolitan: results of the study prevention

Antecedentes: El sobrepeso y la obesidad aumentan el riesgo de padecer enfermedades cardiovasculares y otras patologías que alteran significativamente la calidad y expectativa de vida. Estudios en otras poblaciones de América Latina y el Perú muestran que la prevalencia de obesidad viene aumentando en las últimas décadas. Métodos: PREVENCION es un estudio poblacional realizado en la ciudad de Arequipa entre los años 2004-2006, en el que se obtuvo una muestra probabilística, multietápica y estratificada de adultos no institucionalizados de entre 20-80 años de edad constituida por 1878 individuos (867 varones y 1011 mujeres) pertenecientes a 626 familias. Evaluamos la prevalencia de sobrepeso y obesidad de acuerdo al índice de masa corporal (IMC) y la prevalencia de obesidad abdominal considerando el perímetro de cintura (PC). Resultados: El valor promedio del IMC en la población fue 26.2 kg/m2 (IC al 95 por ciento = 25.9û26.5 kg/m2). Las prevalencias estandarizadas por edad de obesidad (IMC≥30) y sobrepeso (IMC = 25.0û29.9) fueron 17.6 por ciento (IC al 95 por ciento=15.7û19.6 por ciento) y 41.8 por ciento (IC al 95 por ciento=39.3û44.4 por ciento), respectivamente. La prevalencia de obesidad fue más alta en mujeres (20.5 por ciento; IC al 95 por ciento=17.9-23.2 por ciento) que en hombres (14.7 por ciento; IC al 95 por ciento=12.3-17.5 por ciento; p=0.001). Sin embargo, la prevalencia de sobrepeso fue mayor en hombres (47.8 por ciento; IC al 95 por ciento=44.1-51.5 por ciento) que en mujeres (35.9 por ciento; IC al 95 por ciento=32.7-39.1 por ciento ; p<0.001), de modo que el 37.4 por ciento de hombres y el 43.7 por ciento de mujeres presentaron un IMC<25.0. La prevalencia de obesidad abdominal según los criterios del ATP III fue de 15.2 por ciento (IC al 95 por ciento=12.8-18.1 por ciento) en hombres y 39.7 por ciento (IC al95 por ciento=36.3-43.2 por ciento) en mujeres (p<0.0001). A su vez, las prevalencias de obesidad abdominal en hombres y mujeres...

Prevalencia de sobrepeso y obesidad en la población adulta de Arequipa Metropolitana: resultados del estudio prevención / Prevalencia of overweight and obesity in the adult population of Arequipa Metropolitan: results of the study prevention

Antecedentes: El sobrepeso y la obesidad aumentan el riesgo de padecer enfermedades cardiovasculares y otras patologías que alteran significativamente la calidad y expectativa de vida. Estudios en otras poblaciones de América Latina y el Perú muestran que la prevalencia de obesidad viene aumentando en las últimas décadas. Métodos: PREVENCION es un estudio poblacional realizado en la ciudad de Arequipa entre los años 2004-2006, en el que se obtuvo una muestra probabilística, multietápica y estratificada de adultos no institucionalizados de entre 20-80 años de edad constituida por 1878 individuos (867 varones y 1011 mujeres) pertenecientes a 626 familias. Evaluamos la prevalencia de sobrepeso y obesidad de acuerdo al índice de masa corporal (IMC) y la prevalencia de obesidad abdominal considerando el perímetro de cintura (PC). Resultados: El valor promedio del IMC en la población fue 26.2 kg/m2 (IC al 95 por ciento = 25.9û26.5 kg/m2). Las prevalencias estandarizadas por edad de obesidad (IMC≥30) y sobrepeso (IMC = 25.0û29.9) fueron 17.6 por ciento (IC al 95 por ciento=15.7û19.6 por ciento) y 41.8 por ciento (IC al 95 por ciento=39.3û44.4 por ciento), respectivamente. La prevalencia de obesidad fue más alta en mujeres (20.5 por ciento; IC al 95 por ciento=17.9-23.2 por ciento) que en hombres (14.7 por ciento; IC al 95 por ciento=12.3-17.5 por ciento; p=0.001). Sin embargo, la prevalencia de sobrepeso fue mayor en hombres (47.8 por ciento; IC al 95 por ciento=44.1-51.5 por ciento) que en mujeres (35.9 por ciento; IC al 95 por ciento=32.7-39.1 por ciento ; p<0.001), de modo que el 37.4 por ciento de hombres y el 43.7 por ciento de mujeres presentaron un IMC<25.0. La prevalencia de obesidad abdominal según los criterios del ATP III fue de 15.2 por ciento (IC al 95 por ciento=12.8-18.1 por ciento) en hombres y 39.7 por ciento (IC al95 por ciento=36.3-43.2 por ciento) en mujeres (p<0.0001). A su vez, las prevalencias de obesidad abdominal en hombres y mujeres...